Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 06 2025
0mins
Source: Globenewswire
Public Offering Announcement: Pasithea Therapeutics has priced a public offering of 3,571,428 shares of common stock and accompanying warrants at $1.40 per share, aiming to raise approximately $5 million for general corporate purposes, including ongoing research and clinical trials.
Forward-Looking Statements: The company issued forward-looking statements regarding the completion of the offering, the success of its clinical trials, and potential future business strategies, while cautioning that actual results may differ due to various risks and uncertainties.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
